GSKJ-4

N/A

Report date: 2025/03/19 13:49:15
NME

Base Information

Drug NameGSKJ-4
Drug Alias NameGSKJ-4GSK-J4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysine-specific demethylase 6A inhibitorsLysine-specific demethylase 6B inhibitors
TargetsLysine-specific demethylase 6ALysine-specific demethylase 6B
Therapy Area/IndicationsRenal fibrosisCardiomyopathiesLeukemia, Myeloid, Acute +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsRenal fibrosisCardiomyopathiesLeukemia, Myeloid, Acute
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A